Cargando…

Additional Chemotherapy with 5-FU plus Leucovorin between Preoperative Chemoradiotherapy and Surgery Improved Treatment Outcomes in Patients with Advanced Rectal Cancer

Purpose: The aim of the preliminary study was to evaluate the efficacy and safety of 4-week chemotherapy with 5-Fluorouracil and leucovorin (LV5FU2) during the resting periods between preoperative CRT and surgery in patients with LARC. Materials and Methods: Standard preoperative CRT was delivered t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Song Ee, Choi, Jin Hwa, Choi, Chang Hwan, Park, Suk Won, Kim, Beon Gyu, Cha, Seong Jae, Hwang, In Gyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329867/ https://www.ncbi.nlm.nih.gov/pubmed/30662539 http://dx.doi.org/10.7150/jca.25366

Ejemplares similares

Sarcopenia is poor prognostic factor in older patients with locally advanced rectal cancer who received preoperative or postoperative chemoradiotherapy
por: Park, Song Ee, et al.
Publicado: (2018)

Effect of leukocyte alteration on treatment outcomes following preoperative chemoradiotherapy in patients with rectal cancer
por: Kim, Tae Gyu, et al.
Publicado: (2017)

A Phase II Study of Preoperative Chemoradiotherapy with Capecitabine Plus Simvastatin in Patients with Locally Advanced Rectal Cancer
por: Jo, Hyunji, et al.
Publicado: (2023)

A phase II study of preoperative chemoradiation with tegafur-uracil plus leucovorin for locally advanced rectal cancer with pharmacogenetic analysis
por: Kim, Sun Young, et al.
Publicado: (2017)

Pathological Complete Response of Advanced Rectal Cancer Treated by Preoperative Chemoradiotherapy with Oral Tegafur-Uracil and Leucovorin: A Case Report
por: Wakasugi, Masaki, et al.
Publicado: (2013)

Additional Chemotherapy During Resting Periods After Preoperative Chemoradiotherapy in Patients With Rectal Cancer
por: Bae, Ok Suk
Publicado: (2013)

Efficacy and short-term outcomes of preoperative chemoradiotherapy with intermittent oral tegafur-uracil plus leucovorin in Japanese rectal cancer patients: a single center experience retrospective analysis
por: Nakagawa, Ryosuke, et al.
Publicado: (2017)

Clinical predictive factors of pathologic tumor response after preoperative chemoradiotherapy in rectal cancer
por: Choi, Chi Hwan, et al.
Publicado: (2012)

Preoperative Concurrent Chemoradiotherapy for Locally Advanced Rectal Cancer: Treatment Outcomes and Analysis of Prognostic Factors
por: Kong, Moonkyoo, et al.
Publicado: (2012)

Erratum to: Efficacy and short-term outcomes of preoperative chemoradiotherapy with intermittent oral tegafur-uracil plus leucovorin in Japanese rectal cancer patients: a single center experience retrospective analysis
por: Nakagawa, Ryosuke, et al.
Publicado: (2017)

Phase II study of preoperative radiation plus concurrent daily tegafur-uracil (UFT) with leucovorin for locally advanced rectal cancer
por: Cellier, Patrice, et al.
Publicado: (2011)

Effectiveness of Adjuvant Chemotherapy with 5-FU/Leucovorin and Prognosis in Stage II Colon Cancer
por: Jee, Sun Hee, et al.
Publicado: (2011)

Clinical outcomes of chemoradiotherapy for locally recurrent rectal cancer
por: Lee, Joo Ho, et al.
Publicado: (2011)

Predictors of pathologic complete response after preoperative concurrent chemoradiotherapy of rectal cancer: a single center experience
por: Choi, Euncheol, et al.
Publicado: (2016)

Clinical Outcomes of Local Excision Following Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer
por: Lee, Nam Kwon, et al.
Publicado: (2014)

Comparison of two preoperative chemoradiotherapy regimens for locally advanced rectal cancer: capecitabine alone versus capecitabine plus irinotecan
por: Lee, Sung Uk, et al.
Publicado: (2013)

Predicting multi-class responses to preoperative chemoradiotherapy in rectal cancer patients
por: Gim, Jungsoo, et al.
Publicado: (2016)

Is Preoperative Chemoradiotherapy Beneficial for Sphincter Preservation in Low-Lying Rectal Cancer Patients?
por: Park, In Ja, et al.
Publicado: (2016)

Preoperative short- vs. long-course chemoradiotherapy with delayed surgery for locally advanced rectal cancer
por: Chung, Mi Joo, et al.
Publicado: (2016)

Does total regression of primary rectal cancer after preoperative chemoradiotherapy represent “no tumor” status?
por: Jeong, Seong-A, et al.
Publicado: (2019)

Efficacy of hypofractionated preoperative chemoradiotherapy in rectal cancer
por: Cho, Ick Joon, et al.
Publicado: (2023)

Influence of Preoperative Chemoradiotherapy on the Surgical Strategy According to the Clinical T Stage of Patients With Rectal Cancer
por: Park, In Ja, et al.
Publicado: (2015)

Simultaneous integrated boost intensity-modulated radiotherapy versus 3-dimensional conformal radiotherapy in preoperative concurrent chemoradiotherapy for locally advanced rectal cancer
por: Bae, Bong Kyung, et al.
Publicado: (2017)

Long-term outcomes of surgery alone versus surgery following preoperative chemoradiotherapy for early T3 rectal cancer: A propensity score analysis
por: Cho, Seung Hyun, et al.
Publicado: (2017)

Preoperative Chemoradiation in Locally Advanced Rectal Cancer: A Comparison of Bolus 5-Fluorouracil/Leucovorin and Capecitabine
por: Yoney, Adnan, et al.
Publicado: (2014)

Retrospective study of preoperative chemoradiotherapy with capecitabine versus capecitabine plus oxaliplatin for locally advanced rectal cancer
por: Yang, Xiao-Hui, et al.
Publicado: (2020)

Correlation between T stage and lymph node metastasis in rectal cancer treated with preoperative chemoradiotherapy
por: Kim, Seijong, et al.
Publicado: (2022)

Early Systemic Failure After Preoperative Chemoradiotherapy for the Treatment of Patients With Rectal Cancer
por: Choi, Taesun, et al.
Publicado: (2019)

Clinical Significance of Tumor Regression Grade in Rectal Cancer with Preoperative Chemoradiotherapy
por: Park, Young Joo, et al.
Publicado: (2010)

Gene expression levels of gamma-glutamyl hydrolase in tumor tissues may be a useful biomarker for the proper use of S-1 and tegafur-uracil/leucovorin in preoperative chemoradiotherapy for patients with rectal cancer
por: Sadahiro, Sotaro, et al.
Publicado: (2017)

A review of preoperative chemoradiotherapy for lower rectal cancer
por: Beppu, Naohito, et al.
Publicado: (2018)

What Is the Ideal Tumor Regression Grading System in Rectal Cancer Patients after Preoperative Chemoradiotherapy?
por: Kim, Soo Hee, et al.
Publicado: (2016)

Preoperative chemoradiotherapy followed by local excision in clinical T2N0 rectal cancer
por: Shin, Young Seob, et al.
Publicado: (2016)

Beware of Early Relapse in Rectal Cancer Patients Treated With Preoperative Chemoradiotherapy
por: Oh, Seul Gi, et al.
Publicado: (2020)

A phase I study of oral UFT/leucovorin and irinotecan, plus radiation for locally recurrent rectal cancer
por: Ikeda, Masataka, et al.
Publicado: (2018)

Irinotecan Plus S-1 Followed by Hepatectomy for a Patient with Initially Unresectable Colorectal Liver Metastases, Who Showed Severe Drug Rash with Oxaliplatin Plus 5-FU and Leucovorin (FOLFOX)
por: Komori, Hiroyuki, et al.
Publicado: (2014)

Efficacy of preoperative chemoradiotherapy in patients with cT2N0 distal rectal cancer
por: Park, Min Young, et al.
Publicado: (2023)

Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer
por: Rao, S, et al.
Publicado: (2005)

Preoperative Chemoradiotherapy in Elderly Patients with Locally Advanced Rectal Cancer
por: De Felice, Francesca, et al.
Publicado: (2013)

Effect of preoperative chemoradiotherapy on the immunological status of rectal cancer patients
por: Yasui, Kazuaki, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0539bfu96alk1qg95u0o6ladue